Endpoints News Manufacturing Day 2024
Orientation Marketing is partnering with Endpoints to deliver a top level event on key global supply topics of complexity, geopolitical considerations, reliability and future proofing, featuring top KOLs across the pharma manufacturing industry including John Chiminski, former CEO and Chair of Catalent, Bill Humphries, CEO of Alcami, Haylee Crowe, EVP of Ecolab and Christian Jones, CCO of Nanoform.
Pharmaceutical manufacturing is under a heavy spotlight. Policymakers are focused on the relationships between pharma companies and their manufacturing partners, and high-demand medications are stretching the limits of production. Join Endpoints for sessions focused on the latest trends and pressure points, and hear how leading experts are reacting to a fast-changing landscape.
Agenda - Tuesday, August 6th (all times are EDT)
11:00am - Global Tensions, Local Opportunities
11:35am - Your Partners’ C-Suite View: Navigating Manufacturing Partnerships Through Turbulent Times
12:20pm - The GLP1 Compounding Gray Area: A Fireside Conversation with NABP Executive Director Lemrey “Al” Carter
Your Partners’ C-Suite View: Navigating Manufacturing Partnerships Through Turbulent Times
Sponsored by Orientation Marketing:
Bill Humphries, CEO, Alcami Corporation
Hayley Crowe, EVP & General Manager, Global Life Sciences, Ecolab
John Chiminski, Former Chairman and CEO of Catalent Pharma Solutions
Christian Jones, CCO, Nanoform
High demand for pharma manufacturing, driven by patients’ needs and scientific breakthroughs, is creating an industry imperative to provide additional, reliable supply, despite increasing complexities and disruptions. Hear from C-suite CDMO experts about how they are partnering with innovators to overcome the challenges facing global supply, regulatory disruptions, multiple modalities in the development pipeline, complexity, and rising costs. Featuring guest speakers: John Chiminski, former Catalent CEO and Chair; Bill Humphries, CEO of Alcami; Christian Jones, CCO of Nanoform; and Hayley Crowe, EVP, Pharma at Ecolab; and moderated by Kurt Nielsen, Ph.D., former CEO at Pii and CTO at Catalent.
Global Tensions, Local Opportunities
Anton Gerdenitsch, Head CMO, Novartis
Anna Brown, News Reporter, Endpoints News
Between the BIOSECURE Act in the US, China’s tightened espionage laws, and worry about Covid-esque global disruption, biopharma companies all over the world are taking a close look at the maps of their supply chains. Some are making the call to move things closer to home. Join our panelists to explore why and how manufacturing is (or is not) shifting domestically.
The GLP1 Compounding Gray Area: A Fireside Conversation with NABP Executive Director Lemrey “Al” Carter
Lemrey “Al” Carter, Executive Director/ Secretary, National Association of Boards of Pharmacy
Nicole DeFeudis, Editor, Endpoints New
The rush for GLP1 drugs and subsequent shortages have opened the door for compounding pharmacies to make versions of the medication. But the quality of those versions is sometimes questionable — as is the legality. FDA has issued warnings, state boards of pharmacy have put out notices, and drugmakers have filed lawsuits. What comes next? Join us as reporter Nicole DeFeudis talks with the head of the National Association of Boards of Pharmacy about the messy landscape.
